NINJ1 and atrial fibrillation: In the current study, we evaluated Ninj1 plasma levels in patients with or without AF, investigated the underlying value of plasma Ninj1 as a biomarker in AF, and explored the association between plasma Ninj1 and thromboembolic risk.